Skip to content

The randomized duble blind parallel-group comparison test of the effect for eyestrain of the functional food including Bilberry extracts

The randomized duble blind parallel-group comparison test of the effect for eyestrain of the functional food including Bilberry extracts - The test of the effect for eyestrain of the functional food including Bilberry extracts

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000015253
Enrollment
30
Registered
2014-09-26
Start date
2014-09-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eyestrain

Interventions

control group test sample1 group test sample2 group

Sponsors

Department of Ophthalmology , Health Sciences University of Hokkaido Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Subjects who are aware of eyestrain. Subjects who ageree to participate in the current study with written informed consent.

Exclusion criteria

Exclusion criteria: Subjects who have serious historical disease of ophhalmopathy or have morbidity. Subjects who daily ingest drugs or health foods which would improve eyestrain. Subjects who have serious historical disease or have morbidity, marked impairment of heart, lung,liver, kidney, heart, or gastrointestinal tract functions (excluding extirpation of vermiform appendix). Subjects suspected that accommodative asthenopia or other non-neurogenic. Pregnant and lactating female, or who wish to get pregnant during the study period. Subjects who participate in other clinical trials within the last 4 weeks prior to the current clinical trial. Subjects who are ineligible due to physician's judgment.

Design outcomes

Primary

MeasureTime frame
Near-reflex

Secondary

MeasureTime frame
Dry eye test, Fundus blood flow speed, Visual analog scale, Physical examinations, Blood test, Urine test and adverse event

Countries

Japan

Contacts

Public ContactTomita Shimpei

New drug research center, Inc. Clinical Research Dept.

s-tomita@ndrcenter.co.jp0123-34-0412

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026